{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:05:07Z","timestamp":1785326707857,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2019R1A2C2085462"],"award-info":[{"award-number":["NRF-2019R1A2C2085462"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Concomitant amyloid pathology is not uncommon and contributes to the clinical characteristics of Lewy body disease (LBD). We investigated the effect of amyloid on striatal<jats:sup>18<\/jats:sup>F-FP-CIT uptake patterns in LBD, including Parkinson's disease (PD) and dementia with Lewy bodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled 125 patients with LBD who underwent<jats:sup>18<\/jats:sup>F-florbetaben positron emission tomography (PET) and<jats:sup>18<\/jats:sup>F-FP-CIT PET. Patients were divided into amyloid-positive and amyloid-negative groups. We investigated the effect of amyloid on striatal dopamine transporter (DAT) availability, depending on the type of LBD, using general linear models with interaction analysis after controlling for age, sex, education, deep white matter hyperintensity (WMH), periventricular WMH, and cognitive status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a significant interaction effect between the disease group and the presence of amyloid on DAT availability in the anterior putamen, posterior putamen, caudate, and ventral striatum. In the presence of amyloid, only the PD group exhibited decreased DAT availability in the anterior and posterior putamen. In both groups, the presence of amyloid was not associated with DAT availability in the caudate and ventral striatum. The presence of amyloid was not directly related to the worse parkinsonian motor symptoms in both groups. However, there was a significant indirect effect of amyloid on parkinsonian motor symptoms, which was mediated by anterior and posterior putaminal DAT availability in the PD group alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study demonstrates different amyloid-dependent or amyloid-independent<jats:sup>18<\/jats:sup>F-FP-CIT PET patterns in patients with LBD, suggesting distinctive interactions between \u03b1-synuclein and amyloid pathology based on the type of LBD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2023.1196602","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T07:57:28Z","timestamp":1691481448000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Distinct amyloid-dependent patterns of nigra dopamine depletion in Lewy body diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Kyoungwon","family":"Baik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mincheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younggun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Soo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch. Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2113489119","DOI":"10.1073\/pnas.2113489119","article-title":"Different \u03b1-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy","volume":"119","author":"Ayers","year":"2022","journal-title":"Proc. Nat. Acad. Sci."},{"key":"B3","unstructured":"Distinct amyloid-dependent patterns of nigral dopamine depletion in Lewy body diseases. Mov. Disord.\n            BaikK.\n            ChaJ.\n            ParkM.\n            LeeY.\n            KangS. W.\n            YoonS. H.\n          2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1212\/WNL.0000000000007747","article-title":"Subthreshold amyloid and its biological and clinical meaning: long way ahead","volume":"93","author":"Bischof","year":"2019","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab180","article-title":"The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study","author":"Biundo","year":"2021","journal-title":"Brain Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ana.25446","article-title":"Seeding variability of different alpha synuclein strains in synucleinopathies","volume":"85","author":"Candelise","year":"2019","journal-title":"Ann. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neuroimage.2004.06.045","article-title":"The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease","volume":"23","author":"Colloby","year":"2004","journal-title":"Neuroimage"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of \u03b1-synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Colom-Cadena","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","article-title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","volume":"95","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","article-title":"Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia","volume":"486","author":"Fujishiro","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000441421","article-title":"PET radioligands reveal the basis of dementia in Parkinson's disease and dementia with Lewy bodies","volume":"16","author":"Gomperts","year":"2016","journal-title":"Neurodegen. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00401-020-02163-5","article-title":"Evidence of distinct \u03b1-synuclein strains underlying disease heterogeneity","volume":"142","author":"Holec","year":"2021","journal-title":"Acta Neuropathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J. Neural. Transm."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-023-02660-3","article-title":"Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia","author":"Jellinger","year":"2023","journal-title":"J. Neural Transm."},{"key":"B20","volume-title":"PETempler. GitHub Repository","author":"Kim","year":"2020"},{"key":"B21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","article-title":"101 labeled brain images and a consistent human cortical labeling protocol","volume":"6","author":"Klein","year":"2012","journal-title":"Front. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mds.27252","article-title":"Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases","volume":"33","author":"Lee","year":"","journal-title":"Mov. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2018.08.007","article-title":"Amyloid-\u03b2-related and unrelated cortical thinning in dementia with Lewy bodies","volume":"72","author":"Lee","year":"","journal-title":"Neurobiol. Aging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-014-0052-7","article-title":"Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11 C altropane positron emission tomography study","volume":"6","author":"Marquie","year":"2014","journal-title":"Alzheimer's Res. Therapy"},{"key":"B26","volume-title":"Network Failure, Atrophy, and Tau Pathology in Aphasic Alzheimer Disease","author":"Martersteck","year":"2020"},{"key":"B27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/jnnp-2015-312690","article-title":"Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease","volume":"87","author":"McMillan","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acn3.51482","article-title":"Quantifying regional \u03b1-synuclein, amyloid \u03b2, and tau accumulation in lewy body dementia","volume":"9","author":"Miller","year":"2022","journal-title":"Annals Clin. Trans. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mds.25213","article-title":"beta-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia","volume":"28","author":"Muller","year":"2013","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O'Brien","year":"2004","journal-title":"Arch. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","article-title":"A\u03b2-amyloid deposition in patients with Parkinson disease at risk for development of dementia","volume":"79","author":"Petrou","year":"2012","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00259-019-04324-5","article-title":"Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123 I-FP-CIT SPECT study","volume":"46","author":"Pilotto","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder","volume":"135","author":"Postuma","year":"2012","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s002590100571","article-title":"Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease","volume":"28","author":"Ransmayr","year":"2001","journal-title":"Eur. J. Nucl. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","article-title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimer's & dementia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/aww193","article-title":"Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with Lewy bodies","volume":"139","author":"Sarro","year":"2016","journal-title":"Brain"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195172805.001.0001","volume-title":"Statistical Analysis of Epidemiologic Data.","author":"Selvin","year":"2004"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s12035-020-01913-6","article-title":"Polymorphic \u03b1-synuclein strains modified by dopamine and docosahexaenoic acid interact differentially with tau protein","volume":"57","author":"Sengupta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","article-title":"Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease","volume":"93","author":"Shirvan","year":"2019","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/nan.12308","article-title":"Lewy-and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum","volume":"42","author":"Sierra","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology","volume":"131","author":"Toledo","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00401-020-02157-3","article-title":"The structural differences between patient-derived \u03b1-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies","volume":"139","author":"Van der Perren","year":"2020","journal-title":"Acta Neuropathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy","volume":"78","author":"Walker","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1344","DOI":"10.1212\/WNL.0000000000009168","article-title":"Clinical and striatal dopamine transporter predictors of beta-amyloid in dementia with Lewy bodies","volume":"94","author":"Yoo","year":"2020","journal-title":"Neurology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/WAD.0000000000000007","article-title":"The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles","volume":"28","author":"Yoon","year":"2014","journal-title":"Alzheimer Dis. Assoc. Dis."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1196602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T07:57:33Z","timestamp":1691481453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1196602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":49,"alternative-id":["10.3389\/fnagi.2023.1196602"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1196602","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"article-number":"1196602"}}